Position in LLY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$28,233,385
+$6,881,845 QoQ
Shares Held
23,539
+1.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#740
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026North Dakota State Investment Board holds $88,845,781 across 9 Drug Manufacturers - General names. LLY ranks #1 (31.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
23,539 | $28,233,385 | |
| 2 | JNJ |
Johnson & Johnson
|
71,036 | $18,041,012 | |
| 3 | ABBV |
AbbVie Inc.
|
52,197 | $13,134,853 | |
| 4 | MRK |
Merck & Co., Inc.
|
72,931 | $9,371,633 | |
| 5 | AMGN |
Amgen Inc
|
15,994 | $5,791,747 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
37,032 | $4,678,622 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
79,632 | $4,588,395 | |
| 8 | PFE |
Pfizer Inc
|
168,928 | $4,067,786 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,233,385 | 23,539 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $21,351,540 | 23,214 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $29,534,358 | 27,482 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||